These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 13896634)

  • 21. Isoniazid plus thioacetazone compared with two regimens of isoniazid plus PAS in the domiciliary treatment of pulmonary tuberculosis in South Indian patients.
    Tuberculosis Chemotherapy Centre
    Bull World Health Organ; 1966; 34(4):483-515. PubMed ID: 4161578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone.
    Evans C; Devadatta S; Fox W; Gangadharam PR; Menon NK; Ramakrishnan CV; Sivasubramanian S; Somasundaram PR; Stott H; Velu S
    Bull World Health Organ; 1969; 41(1):1-16. PubMed ID: 5309083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis.
    Gurumurthy P; Krishnamurthy MS; Nazareth O; Parthasarathy R; Sarma GR; Somasundaram PR; Tripathy SP; Ellard GA
    Am Rev Respir Dis; 1984 Jan; 129(1):58-61. PubMed ID: 6367570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A CLINICAL STUDY OF ISONIAZID INACTIVATION.
    JESSAMINE AG; HAMILTON EJ; EIDUS L
    Can Med Assoc J; 1963 Dec; 89(24):1214-7. PubMed ID: 14084700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A COMPARISON OF THE VIRULENCE IN THE GUINEA-PIG OF TUBERCLE BACILLI FROM THAI AND BRITISH PATIENTS.
    BHATIA AL; JACOB CV; HITZE KL; RAMACHANDRAN K; SELKON JB
    Bull World Health Organ; 1963; 29(4):483-90. PubMed ID: 14099674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis.
    Ellard GA
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 2):610-25. PubMed ID: 773583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotyping of South African black tuberculosis patients for inactivation of isoniazid.
    Eidus L; Glatthaar E; Hodgkin MM; Nel EE; Kleeberg HH
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):243-56. PubMed ID: 461951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of tubercle bacilli from Indian patients with pulmonary tuberculosis.
    THOMAS KL; JOSEPH S; SUBBAIAH T; SELKON JB
    Bull World Health Organ; 1961; 25(6):747-58. PubMed ID: 13920820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Individual differences in the pattern of resistance development of tubercle bacilli to streptomycin, PAS and isoniazid in tuberculous patients].
    TSUKAMURA M
    Kekkaku; 1960 Oct; 35():704-8. PubMed ID: 13778449
    [No Abstract]   [Full Text] [Related]  

  • 31. Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
    Venkataraman P; Menon NK; Nair NG; Radhakrishna S; Ross C; Tripathy SP
    Indian J Med Res; 1972 May; 60(5):685-93. PubMed ID: 4663236
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence and early attack rate of tuberculosis among close family contacts of tuberculous patients in South India under domiciliary treatment with isoniazid plus PAS or isoniazid alone.
    RAMAKRISHNAN CV; ANDREWS RH; DEVADATTA S; FOX W; RADHAKRISHNA S; SOMASUNDARAM PR; VELU S
    Bull World Health Organ; 1961; 26(3):361-407. PubMed ID: 14038589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. THE PREVENTION AND TREATMENT OF ISONIAZID TOXICITY IN THE THERAPY OF PULMONARY TUBERCULOSIS. 2. AN ASSESSMENT OF THE PROPHYLACTIC EFFECT OF PYRIDOXINE IN LOW DOSAGE.
    ZILBER LA; BAJDAKOVA ZL; GARDASJAN AN; KONOVALOV NV; BUNINA TL; BARABADZE EM
    Bull World Health Organ; 1963; 29(4):457-81. PubMed ID: 14099673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid.
    Rao KV; Mitchison DA; Nair NG; Prema K; Tripathy SP
    Br Med J; 1970 Aug; 3(5721):495-7. PubMed ID: 5454342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance. Response to continued treatment for a second year with isoniazid alone or with isoniazid plus PAS.
    RAMAKRISHNAN CV; BHATIA AL; DEVADATTA S; FOX W; NARAYANA AS; SELKON JB; VELU S
    Bull World Health Organ; 1962; 26(1):1-18. PubMed ID: 14490064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Features of isoniazid activation in patients with tuberculosis and diabetes mellitus].
    Karachunskiĭ MA; Kaminskaia GO; Kossiĭ IuE; Chernykh NA
    Probl Tuberk; 2001; (7):26-7. PubMed ID: 11763557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
    Ellard GA
    Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoniazid inactivation in Indian children.
    Desai M; Jariwala G; Khokhani B; Desai NK; Sheth UK
    Indian Pediatr; 1973 Jun; 10(6):373-6. PubMed ID: 4746249
    [No Abstract]   [Full Text] [Related]  

  • 39. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].
    Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
    Am Rev Respir Dis; 1992 Jan; 145(1):36-41. PubMed ID: 1731596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.